News

The botulinum toxin market is projected to grow at a CAGR of approximately 10% from 2025 to 2030. This growth is driven by ...
The global Botulinum Toxins Market, valued at US$8.1 billion in 2024 stood at US$8.9 billion in 2025 and is projected to ...
The global Botulinum Toxins Market, valued at US$8.1 billion in 2024 stood at US$8.9 billion in 2025 and is projected to advance at a resilient ...
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the c ...
(RTTNews) - Galderma Group AG announced that Thomas Dittrich, Chief Financial Officer, will be leaving the company to pursue another senior executive opportunity outside the organization. A ...
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating ...
Overview of Medical Aesthetics MarketThe global Medical Aesthetics Market is valued at USD 38 Billion in 2024 and is ...
Investing.com - UBS downgraded Galderma Group AG (SWX:GALD) from Buy to Neutral on Monday, while lowering its price target to CHF120.00 from CHF128.00.
Toxins and invasive amoebas found in marina seabed sediments by University of Gothenburg edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...